ASFNR Programming: Advanced Neuroimaging Techniques in Brain Tumor: Current Updates: Self Assessment Module (SAM) SAM

Peter B. Barker, D.Phil; Kirk M. Welker, MD; Jerrold Boxerman, MD, PhD; Whitney B. Pope, MD, PhD

Supported Browsers/Devices to view this course:

The numbers in the table specify the first compatible browser version.

4.0+ 9.0+ 3.5+ 4.0+ 10.5+ 1.0+ 2.0+

Whichever browser you prefer, please use the most up-to-date version available to ensure that everything on the site works smoothly

If you have difficulties viewing the presentation, please contact our webmaster for help.



Target Audience:

The ASNR 54th Annual Meeting is the premier Neuroradiology meeting in the world. The target audience includes:

  • Neuroradiologists in practice and research
  • General radiologists who read Neuroradiology studies
  • Young professionals and trainees
  • Brain, Spine, and Head and Neck imaging Scientists
  • Clinicians from related disciplines

About This Module:

This module is composed of four parts:
  • Proton MR Spectroscopy Peter B. Barker, D.Phil
  • Functional MRI Pre-Treatment Planning for Brain Tumor: Pitfalls and Progress Kirk M. Welker, MD
  • Treatment Response from Pseudoprogression Jerrold Boxerman, MD, PhD
  • Diffusivity and Genomics: Current Thoughts and Metrics Whitney B. Pope, MD, PhD

Objectives:

Upon completion of this module, participants should be able to:

Part I:Proton MR Spectroscopy Peter B. Barker, D.Phil

  • Identify markers of tumors in MR spectroscopy; describe potential uses of MRS in diagnosis, radiotherapy planning and treatment monitoring.

Part II:Functional MRI Pre-Treatment Planning for Brain Tumor: Pitfalls and Progress Kirk M. Welker, MD

  • Describe the role and uses of fMRI for brain tumor presurgical planning, with particular attention to language mapping. List the benefits and pitfalls of fMRI in this context.

Part III:Treatment Response from Pseudoprogression Jerrold Boxerman, MD, PhD

  • Evaluate the response of gliomas to treatment via DSC-MRI of cerebral blood volume; distinguish between pseudoprogression and progressive disease; distinguish between pseudoresponse and true response.

Part IV:Diffusivity and Genomics: Current Thoughts and Metrics Whitney B. Pope, MD, PhD

  • Define the relationship between molecular markers of malignancy and qualitative and quantitative glioma image data; recognize the potential and limitations of genomic-imaging (radiogenomic) correlation for understanding glioma biology.

Commercial Support

No commercial support was received for this activity.

Accreditation Statement

The American Society of Neuroradiology (ASNR) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

ASNR designates this enduring material for a maximum of AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Method of Physician Participation:

Each physician will listen to each audio self-directed module while following along with the visual slides. Upon completion, each physician will answer evaluation questions and pass a post test with at least a score of 80% to receive their CME certificate.

Disclosures: All individuals in control of content have disclosed the following relevant financial relationships. All of these relationships were treated as a conflict of interest, and have been resolved (C7 SCS 6.1-6.2, 6.5)

Planner(s):

  • Howard A. Rowley, MD, 2016 Program Chair/President-Elect, has no relevant financial relationships.
  • C. Douglas Phillips, MD, FACR, Chair, Web and Online Education Subcommittee of ASNR Education Committee, has no relevant financial relationships.
  • Angelo Artemakis, ASNR staff, has no relevant financial relationships.

Presenter(s):

  • Peter B. Barker, D.Phil, has no relevant financial relationships.
  • Kirk M. Welker, MD, has no relevant financial relationships.
  • Jerrold Boxerman, MD, PhD, has no relevant financial relationships.
  • Whitney B. Pope, MD, PhD, Consultant for:
    • Genentech
    • Exelixis
    • Amgen
    • Tocagen
    • Celldex

Contact Information:

If you have questions regarding this enduring material activity, please contact us at meetings@asnr.org.

Privacy Policy and Confidentiality Policy:

The ASNR does not share your personal information provided to this site with any third party, except where required by CME governing bodies for verification of CME activities. Your email address will only be used to contact you in relation to your activities on the website, except where you have given ASNR permission to contact you with additional information. ASNR adheres to the same policy for members as nonmembers, except that: ASNR member mailing address information may be shared with providers of accredited CME activities.


Copyright © Individual presentations copyrighted by individual presentation authors.
All rights reserved. Presentations used with permission.
Other site materials Copyright © American Society of Neuroradiology
2002-